The Brand-Driven Flywheel: Igniting Growth Through a Simple Patient Experience
Direct-to-patient (DTP) models create a continuous loop of value, connecting seamless patient and provider experience with the strategic power of branding and data.
Direct-to-patient (DTP) models create a continuous loop of value, connecting seamless patient and provider experience with the strategic power of branding and data.
It’s time to break down the myths holding the pharmacy sector back, and the emerging realities shaping a new, tech-enabled approach to adherence that blends operational redesign, AI innovation and equity-focused care.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
By embracing innovation, optimizing operations and advocating for change, pharmacy leaders can ensure their organizations are not only prepared for the future but are actively shaping it.
At a time when 98 million prescriptions are abandoned due to cost surprises, it’s critical that all four categories of prescription drug prices are available so consumers can determine how to obtain needed medications at the lowest cost.
Temperature-sensitive medications represent one of the most critical operational and regulatory challenges in modern pharmacy management.
A handful of states have issued guidance documents that illustrate how regulators are viewing the IV hydration and IV therapy businesses, which infusion providers should consider as part of their overall compliance monitoring efforts.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
A quick conversation about coverage, availability and pricing can help patients make informed decisions.
When control over prescription drug access rests with only a few players, the result is not just market imbalance — it is higher plan costs, increased financial pressures, and ultimately reduced affordability for patients.
The real story isn’t about denial rates or stakeholders acting as villains. It’s about a healthcare system that forces intelligent, well-intentioned professionals to make critical decisions in information silos.
AI can now flag where patients are getting stuck — from enrollment delays to dropped calls — while also enabling new, compliant ways to analyze these interactions at scale. But surfacing the issue is just the first step.
Creating a specialty pharmacy in a space-challenged hospital campus can seem like a daunting task, particularly in a crowded metropolitan or suburban area. Here are some creative solutions to solve for this barrier.
Ochsner Health is expanding its use of Latent Health’s AI platform after its reduced medication prior authorization times to just 4-5 minutes. The technology is designed to both streamline pharmacists’ workflows as well as improve patients’ access to medications.
Novo Nordisk is licensing rights to a United Biotechnology drug that sparks metabolic effects by binding to and activating receptors for GLP-1, GIP, and glucagon. Separately, the pharma giant said its recently announced discounted price for obesity medication Wegovy is now expanding to traditional pharmacies.